Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.jviromet.2005.03.004
Title: Characterization of monoclonal antibody against SARS coronavirus nucleocapsid antigen and development of an antigen capture ELISA
Authors: He, Q.
Du, Q.
Lau, S.
Manopo, I.
Lu, L.
Chan, S.-W. 
Fenner, B.J.
Kwang, J. 
Keywords: ELISA
Monoclonal antibody
Nucleocapsid
SARS coronavirus
Severe acute respiratory syndrome
Issue Date: 2005
Source: He, Q., Du, Q., Lau, S., Manopo, I., Lu, L., Chan, S.-W., Fenner, B.J., Kwang, J. (2005). Characterization of monoclonal antibody against SARS coronavirus nucleocapsid antigen and development of an antigen capture ELISA. Journal of Virological Methods 127 (1) : 46-53. ScholarBank@NUS Repository. https://doi.org/10.1016/j.jviromet.2005.03.004
Abstract: This report describes the production of several MAbs against N195 protein, a major immunodomain of SARS CoV nucleocapsid protein [He, Q., Chong, K.H., Chang, H.H., Leung, B., Ling, A.E., Wei, T., Chan, S.W., Ooi, E.E., Kwang, J., 2004. Development of a Western blot assay for detection of antibodies against coronavirus causing severe acute respiratory syndrome. Clin. Diagn. Lab. Immunol. 11 (2) 417-422.]. One representative IgG1 monoclonal antibody (MAb), S-A5D5, was selected and characterized. S-A5D5 reacted specifically react with both recombinant and native nucleocapsid protein of SARS CoV. The reactivity of S-A5D5 with purified N195 protein and utilization of the MAb as a detector antibody to develop an antigen capture ELISA was assessed. As little as 37.5 pg of purified N protein and 50 TCID50 of SARS CoV could be detected by the antigen capture ELISA. Specific binding of the MAb S-A5D5 to both purified N195 and SARS CoV nucleocapsid antigen was effectively inhibited by human SARS positive serum and guinea pig anti-N195 serum. The N protein in N195-spike recombinant baculovirus-infected Sf-9 cells could also be identified. N protein was detected in 18 IFA IgM-positive serum samples collected from SARS confirmed patients, but not in nine samples collected from SARS recovery patient. No false positive results were given when 60 samples from healthy individuals were tested, and no cross-reaction occurred when infectious bronchitis virus (IBV), chicken coronavirus, was tested. This monoclonal antibody-based antigen capture ELISA is thus a powerful tool for early diagnosis of SARS CoV infection. © 2005 Elsevier B.V. All rights reserved.
Source Title: Journal of Virological Methods
URI: http://scholarbank.nus.edu.sg/handle/10635/31469
ISSN: 01660934
DOI: 10.1016/j.jviromet.2005.03.004
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

25
checked on Dec 14, 2017

WEB OF SCIENCETM
Citations

25
checked on Nov 18, 2017

Page view(s)

172
checked on Dec 10, 2017

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.